Merck Fails To Force Trial Of Bellwether Fosamax Case

Law360, New York (December 11, 2008, 12:00 AM EST) -- One of the bellwether plaintiffs in the multidistrict litigation over Merck & Co. Inc.'s osteoporosis drug Fosamax, who tried to drop her claims after Merck obtained a damaging deposition from one of her doctors, has finally gotten a judge's go-ahead to exit the MDL.

On Tuesday, Judge John F. Keenan of the U.S. District Court for the Southern District of New York granted a motion by Karen Denise Greene, one of three plaintiffs chosen for an early bellwether trial, to dismiss her own case.

Plaintiffs in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.